The high cost of prescription eye medications affects over 2 million Americans dealing with vision problems. Patient Assistance Programs (PAPs) offer a vital solution for the underinsured and ...
On January 15, 2025, the U.S. Department of Health and Human Services Office of Inspector General (“OIG”) posted Advisory Opinion 25-01, a favorable opinion analyzing a pharmaceutical manufacturer’s ...
Patients with retinal diseases who were treated with anti-VEGF therapies through manufacturer patient assistance programs ...
On June 17, 2024, the U.S. Department of Health and Human Services Office of Inspector General (“OIG”) posted a favorable Advisory Opinion 24-03 (“AO 24-03”) involving a pharmaceutical manufacturer’s ...
Often referred to as AFPs, alternative funding programs are a third-party entity that works hand-in-hand with self-funded ...
You may qualify for free Restasis through the drug’s manufacturer, myAbbVie Assist. That said, you won’t use your Medicare coverage. Restasis (cyclosporine), a brand-name eye drop for chronic dry eyes ...
Limited evidence from a literature review suggests that co-pay assistance was associated with improved treatment persistence/adherence across various diseases, with indirect evidence suggesting ...
Leemore Dafny ([email protected]), Harvard University, Boston, Massachusetts. Christopher Ody, Northwestern University, Evanston, Illinois. Teresa Rokos, University ...
Associations of Financial Hardship and Health Status, Social Functioning, and Mental Health Among Cancer Survivors in the United States: Findings From a Nationally Representative Study Ulman ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results